Suchergebnisse - "Kayser, Sabine"

PubPharm (127)

11

Q-HAM : a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

enthalten in: Trials | 2023

von Jaramillo, S. | Le Cornet, L. | Kratzmann, M. | +23

12

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

enthalten in: Trials | 2023

von Jaramillo, S. | Le Cornet, L. | Kratzmann, M. | +23

13

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

enthalten in: Trials | 2023

von Jaramillo, S. | Le Cornet, L. | Kratzmann, M. | +23

14

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

15

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

16

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

17

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

enthalten in: Haematologica | February 23, 2023

von Kayser, S. | Ho, A. | Baldus, C. | +4

18

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 17 August 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

19

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

enthalten in: Haematologica | 2023

von Kayser, S. | Martínez-Cuadrón, D. | Rodriguez-Veiga, R. | +29

20

Management of Acute Promyelocytic Leukemia at Extremes of Age

enthalten in: Cancers | 2023

von Kayser, S. | Conneely, S.